SMMT Chart
- 52-Week Range: $0.97 - $8.27
- Market Capitalization: $94.74M
- Short Percentage: 0%
- Target Price: $5.00
- Shares Outstanding: 98.12M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Surface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The DeclineSeeking Alpha | May 25th
- Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common StockGlobeNewsWire | May 25th
- HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022Business Wire | May 25th
- ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing PartnersGlobeNewsWire | May 25th
- Verrica's stock slides after getting second complete response letter from FDAMarket Watch | May 25th
We searched over 50 sources and couldn't find any news or press releases related to Summit Therapeutics.
Here are some articles we think you might like.
Company Info
Website: https://www.summittxinc.com
Address: One Broadway, Cambridge, MA, United States, 02142
Sector: Healthcare
Industry: Biotechnology
Full time employees: 105
Address: One Broadway, Cambridge, MA, United States, 02142
Sector: Healthcare
Industry: Biotechnology
Full time employees: 105
$SMMT green shoots
$SMMT the market is selling off
$SMMT day trade is ok to buy here but sell later
$SMMT Another boring day I believe
$SMMT market starting to dump
$SMMT pressure
$SMMT Buy the dip
$SMMT Many many bears